NICM
ACH

Neo Ivy Capital Management’s Accendra Health ACH Stock Holding History

Neo Ivy Capital Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,090
Closed -$65K – 499
2022
Q2 		$65K Sell
2,090
-2,758
-57% -$99.9K 0.17% 201
2022
Q1 		$214K Buy
4,848
+4,813
+13,751% +$207K 0.19% 185
2021
Q4 		$2K Buy
+35
New +$1.37K ﹤0.01% 410
2021
Q3 		– Sell
-718
Closed -$30K – 584
2021
Q2 		$30K Buy
+718
New +$27.9K 0.03% 353
2021
Q1 		– Sell
-616
Closed -$17K – 591
2020
Q4 		$17K Buy
+616
New +$15.8K 0.02% 366

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neo Ivy Capital Management's ACH Position: Q3 2022 in Review

Neo Ivy Capital Management sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 2,090 shares — an estimated $65K sold.

Neo Ivy Capital Management first reported a position in ACH in Q4 2020 and held it in 5 quarters. The position peaked at $214K in Q1 2022. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Neo Ivy Capital Management reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Neo Ivy Capital Management sold 2,090 Accendra Health shares in Q3 2022, an estimated $65K.
  • Neo Ivy Capital Management first reported a position in Accendra Health in Q4 2020 and held it in 5 quarters.
  • Neo Ivy Capital Management's Accendra Health position peaked at $214K in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Neo Ivy Capital Management's 13F filing for Q3 2022, filed 16 Nov 2022.